Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).

Vähätupa, Maria; Salonen, Niklas; Uusitalo-Järvinen, Hannele; Järvinen, Tero A H

Vähätupa, Maria; Salonen, Niklas; Uusitalo-Järvinen, Hannele; Järvinen, Tero A H.

Afiliação

Vähätupa M; Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Salonen N; Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Uusitalo-Järvinen H; Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Järvinen TAH; Eye Centre & Department of Orthopedics & Traumatology, Tampere University Hospital, 33520 Tampere, Finland.

Pharmaceutics ; 13(11)2021 Nov 15.

Article em En | MEDLINE | ID: mdl-34834347

Palavras-chave

R-Ras; angiogenesis; blood-retina barrier; bronchopulmonary dysplasia; bystander effect; cell penetrating peptide; diabetic retinopathy; heparan sulphate proteoglycan; hypoxia; oxygen-induced retinopathy (OIR); regenerative medicine; retina; retinopathy of prematurity (ROP); targeted delivery; vascular homing peptide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article